跳转至内容

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

Merck
CN
  • Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial.

Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial.

JAMA (2013-11-19)
Francis Kim, Graham Nichol, Charles Maynard, Al Hallstrom, Peter J Kudenchuk, Thomas Rea, Michael K Copass, David Carlbom, Steven Deem, W T Longstreth, Michele Olsufka, Leonard A Cobb
摘要

Hospital cooling improves outcome after cardiac arrest, but prehospital cooling immediately after return of spontaneous circulation may result in better outcomes. To determine whether prehospital cooling improves outcomes after resuscitation from cardiac arrest in patients with ventricular fibrillation (VF) and without VF. A randomized clinical trial that assigned adults with prehospital cardiac arrest to standard care with or without prehospital cooling, accomplished by infusing up to 2 L of 4°C normal saline as soon as possible following return of spontaneous circulation. Adults in King County, Washington, with prehospital cardiac arrest and resuscitated by paramedics were eligible and 1359 patients (583 with VF and 776 without VF) were randomized between December 15, 2007, and December 7, 2012. Patient follow-up was completed by May 1, 2013. Nearly all of the patients resuscitated from VF and admitted to the hospital received hospital cooling regardless of their randomization. The primary outcomes were survival to hospital discharge and neurological status at discharge. The intervention decreased mean core temperature by 1.20°C (95% CI, -1.33°C to -1.07°C) in patients with VF and by 1.30°C (95% CI, -1.40°C to -1.20°C) in patients without VF by hospital arrival and reduced the time to achieve a temperature of less than 34°C by about 1 hour compared with the control group. However, survival to hospital discharge was similar among the intervention and control groups among patients with VF (62.7% [95% CI, 57.0%-68.0%] vs 64.3% [95% CI, 58.6%-69.5%], respectively; P = .69) and among patients without VF (19.2% [95% CI, 15.6%-23.4%] vs 16.3% [95% CI, 12.9%-20.4%], respectively; P = .30). The intervention was also not associated with improved neurological status of full recovery or mild impairment at discharge for either patients with VF (57.5% [95% CI, 51.8%-63.1%] of cases had full recovery or mild impairment vs 61.9% [95% CI, 56.2%-67.2%] of controls; P = .69) or those without VF (14.4% [95% CI, 11.3%-18.2%] of cases vs 13.4% [95% CI,10.4%-17.2%] of controls; P = .30). Overall, the intervention group experienced rearrest in the field more than the control group (26% [95% CI, 22%-29%] vs 21% [95% CI, 18%-24%], respectively; P = .008), as well as increased diuretic use and pulmonary edema on first chest x-ray, which resolved within 24 hours after admission. Although use of prehospital cooling reduced core temperature by hospital arrival and reduced the time to reach a temperature of 34°C, it did not improve survival or neurological status among patients resuscitated from prehospital VF or those without VF. clinicaltrials.gov Identifier: NCT00391469.

材料
货号
品牌
产品描述

Sigma-Aldrich
氯化钠, DNase, RNase, and protease, none detected, ≥99% (titration)
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠 溶液, 0.9% in water, BioXtra, suitable for cell culture
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠 溶液, 5 M in H2O, BioReagent, suitable for cell culture
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
SAFC
氯化钠 溶液, 5 M
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠 溶液, BioUltra, ~5 M in H2O
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, 99.999% trace metals basis
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, BioUltra, ≥99.5% (AT)
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, BioXtra, ≥99.5% (AT)
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, BioPerformance Certified, ≥99% (titration), suitable for insect cell culture, suitable for plant cell culture
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, AnhydroBeads, −10 mesh, 99.999% trace metals basis
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠 溶液, 5 M
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, random crystals, optical grade, 99.9% trace metals basis
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠 溶液, 0.85%
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Supelco
氯化钠, reference material for titrimetry, certified by BAM, >99.5%
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Supelco
氯化钠, Pharmaceutical Secondary Standard; Certified Reference Material
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, Vetec, reagent grade, 99%
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, tablet
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19
Sigma-Aldrich
氯化钠, tested according to Ph. Eur.
登录查看公司和协议定价
货号包装规格是否有货价格数量
1 kit
请联系客服了解存货情况
¥7,017.19